PubRank

Francesca Pentimalli

Author PubWeight™ 38.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Concern Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A 2003 2.52
2 Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 2005 1.53
3 Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther 2010 1.43
4 Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res 2006 1.34
5 HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. Clin Cancer Res 2004 1.23
6 CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci U S A 2010 1.21
7 Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol 2003 1.20
8 Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo. Clin Cancer Res 2005 1.18
9 Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res 2004 1.13
10 HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. Carcinogenesis 2003 1.07
11 Loss of Hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation. FASEB J 2003 1.02
12 The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proc Natl Acad Sci U S A 2003 0.95
13 RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab 2002 0.95
14 Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery. Mass Spectrom Rev 2012 0.94
15 The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endocrinol Metab 2002 0.93
16 The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues. Biochem Biophys Res Commun 2002 0.93
17 Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. Cancer Gene Ther 2004 0.92
18 A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas. Carcinogenesis 2003 0.91
19 Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience. J Exp Clin Cancer Res 2013 0.91
20 Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. Cancer Res 2004 0.91
21 The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. Int J Cancer 2009 0.90
22 ATP-noncompetitive CDK inhibitors for cancer therapy: an overview. Expert Opin Investig Drugs 2013 0.89
23 High mobility group A1 expression correlates with the histological grade of human glial tumors. Oncol Rep 2004 0.89
24 Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review). Oncol Rep 2007 0.89
25 The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records. J Exp Clin Cancer Res 2012 0.88
26 HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. Oncogene 2005 0.87
27 Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma. J Cell Physiol 2010 0.86
28 HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol 2003 0.85
29 Directed in vivo angiogenesis assay and the study of systemic neoangiogenesis in cancer. Int J Cancer 2011 0.84
30 Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias. Oncol Rep 2004 0.84
31 Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition. Cell Cycle 2012 0.83
32 New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells. FASEB J 2010 0.82
33 Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients. Drug News Perspect 2009 0.81
34 Rb family proteins in gastric cancer (review). Oncol Rep 2010 0.80
35 SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment. J Cell Biochem 2015 0.79
36 High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). Biochem J 2005 0.77
37 pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer. J Cell Physiol 2015 0.76
38 Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts. J Cell Biochem 2012 0.76
39 Predicting breast cancer outcome: traditional prognosticators still on center stage. Cancer Biol Ther 2010 0.75
40 Tracking the 2009 H1N1 influenza virus in the Italian region Campania. J Cell Physiol 2012 0.75
41 Transcriptional profile of Ki-Ras-induced transformation of thyroid cells. Cancer Invest 2007 0.75